Real-time enrollment status for this severe asthma clinical trial
Current Status
Recruiting
Checked: July 25, 2026 at 11:48 AM UTC
| NCT Number | NCT07532265 |
| Recruiting Status | Recruiting |
| Condition | Severe Asthma |
| Phase | PHASE2 |
| Target Enrollment | 512 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Kinaset Therapeutics Inc |
| Last Updated on CT.gov | July 24, 2026 (Yesterday) |
As of July 25, 2026: Clinical trial NCT07532265 is currently recruiting participants. This phase2 study for severe asthma is actively seeking new participants at 14 locations across the United States. The study is sponsored by Kinaset Therapeutics Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07532265 is actively recruiting participants as of July 25, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07532265 was last updated Yesterday (July 24, 2026). HelloStudys verifies this status automatically.